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In this study we show that macrophages (Mf) are latently infected with murine cytomegalovirus (MCMV). After clearance
of acute MCMV infection, the predominant form of chronic infection in Balb mice is latency rather than persistence. Peritoneal
exudate cells (PECs) from latently infected Balb mice (3–9 months postinfection) contained MCMV genome and reactivatable
virus. Adherent cells from both resident and thioglycollate-elicited PECs carried more MCMV DNA (measured by PCR) than
nonadherent cells, and were selectively enriched for Mf. FACS sorted F4/80/ Mf contained MCMV DNA, while other
FACS sorted cell populations from PECs were never positive for MCMV DNA. MCMV reactivated from FACS sorted F4/
80/ Mf in 32% of cocultures with murine embryonic fibroblasts (MEFs). Since Mf carry MCMV genome and reactivatable
virus, but not lytic virus, they are latently infected with MCMV. We determined the frequency of Mf carrying MCMV genome
in PECs (about 1/50,000) using a limiting dilution PCR assay. Using this frequency and estimates of the total amount of
MCMV genome in populations, we estimate that latently infected Mf carry 1–10 copies of MCMV genome. To evaluate
the origin of latently infected Mf, we compared the frequency of cells carrying MCMV genome in the resident and elicited
PECs. The frequency of Mf carrying MCMV DNA was the same in resident and thioglycollate-elicited PECs, despite the
fact that there was a ninefold increase in the number of Mf recovered after thioglycollate elicitation. This argued for
recruitment of bone marrow-derived Mf (BMMf) carrying MCMV genome into the peritoneum during inflammatory re-
sponses. Consistent with this hypothesis, MCMV genome, but not persistent virus, was detected in bone marrow cells from
latently infected mice. q 1997 Academic Press
INTRODUCTION MCMV transcripts (Yu et al., 1995; Yuhasz et al., 1994).
Indeed, many studies have argued that little or no infec-
While healthy individuals carry human cytomegalovi-
tious MCMV is present in chronically infected mice (Mer-
rus (HCMV) DNA in the absence of disease, HCMV is a
cer et al., 1988; Balthesen et al., 1993; Jonjic et al., 1994;significant pathogen during immunosuppression or preg-
Mayo et al., 1978; Jordan, 1980), despite the presence ofnancy (Britt and Alford, 1996). Understanding the cellular
MCMV DNA in multiple organs (Klotman et al., 1990;and molecular basis of chronic CMV infection will require
Balthesen et al., 1993; Pomeroy et al., 1991; Pollock anddefinition of the nature of chronic infection (persistence
Virgin, 1995). Recently we showed that the predominantversus latency), identification of cells carrying latent vi-
form of chronic MCMV infection in Balb/c mice is latencyrus, analysis of the latent CMV transcriptional program,
rather than persistence by demonstrating lack of detect-and definition of the role of the immune system in latency
able preformed infectious MCMV in organs that con-and reactivation. We have approached these problems
tained reactivatable MCMV and abundant MCMV ge-using MCMV, a suitable small animal model for HCMV
nome (Pollock and Virgin, 1995). The lack of detectable(reviewed in Vieira et al., 1994; Mocarski, 1996).
virus detected in organs during latency argues againstSeveral studies have addressed the nature of chronic
lack of release of preformed viral particles as a mecha-MCMV infection. Transcriptional activity from the MCMV
nism of latency (Fish et al., 1996, 1995). Reactivation fromimmediate early 1 (ie1) gene, or other genes, has been
latency occurs in vitro in tissue explants (Jordan and Mar,detected in mice recovered from acute MCMV infection
1982; Mercer et al., 1988; Olding et al., 1975; Wilson et(Henry and Hamilton, 1993; Yuhasz et al., 1994; Yu et al.,
al., 1985; Cheung and Lang, 1977; Mayo et al., 1978;1995). This data is consistent with persistent infection,
Pollock and Virgin, 1995) and in vivo when latently in-expression of these gene products during latency, or
fected mice are immunosuppressed (Shanley et al., 1979;abortive reactivation. While these findings have been
Jordan et al., 1977; Jordan, 1980; Balthesen et al., 1993)used to argue for persistence as a form of chronic MCMV
or when latently infected cells are transferred to severeinfection, studies have not demonstrated infectious virus,
combined immunodeficient (SCID) mice (Pollock and Vir-the defining hallmark of persistence, in organs harboring
gin, 1995).
Since chronic MCMV infection in Balb/c mice is pre-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (314) 362-4096. E-mail: virgin@immunology.wustl.edu. dominantly latent, we used this system as a starting point
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for defining latently infected cells. Latently infected cells Viruses and virus stocks
carry the MCMV genome without producing infectious
MCMV Smith strain was obtained from the Americanvirus and retain the ability to reactivate infectious virus.
Type Culture Collection (VR-194, Lot 10). Tissue cultureEfforts to identify latently infected cells in mice chroni-
passaged MCMV (tcMCMV) stocks were generated andcally infected with MCMV have implicated B lymphocytes
stored as previously described (Heise and Virgin, 1995).(Olding et al., 1975; Jordan and Mar, 1982), stromal cells
Salivary gland MCMV (sgMCMV) stocks were made from(Mercer et al., 1988; Pomeroy et al., 1991), and Mf (Brau-
salivary glands of 8-week-old Balb mice infected intraper-tigam et al., 1979) as potential sites of latency. Studies
itoneally (i.p.) with 1 1 105 PFU tcMCMV 17 days priorof chronic infection with HCMV have shown that the Mf
to harvest as previously described (Pollock and Virgin,lineage is a likely source of latently infected cells in
1995).seropositive persons (see Discussion). We favor the hy-
pothesis that tissue latency is best explained by the emi-
gration of latently infected cells into tissues since (i) Mice, mouse infections, and cell harvests
blood cells are well known to transfer latent CMV infec-
Balb/c mice (National Cancer Institute, Frederick, MD)tion, (ii) infiltrating cells are prominently infected in immu-
were infected i.p. with 1–2 1 104 PFU sgMCMV andnocompromised host tissues (Nelson et al., 1990; Gnann
rested for 3–9 months to establish latent infection. Perito-et al., 1988), and (iii) the amount of replicating MCMV in
neal cells were obtained from untreated mice or froma tissue during acute infection does not predict the
mice injected i.p. with 2–3 ml 3% thioglycollate (Becton –amount of latent viral genome present in a tissue during
Dickinson, Cockeysville, MD) solution 3 days prior tochronic infection (Balthesen et al., 1994).
sacrifice. PECs were harvested by peritoneal lavageWe show here that adherent and FACS-sorted inflam-
(Heise and Virgin, 1995).matory Mf from latently infected mice harbor MCMV
DNA in the absence of detectable preformed infectious
virus. MCMV reactivated from FACS-sorted inflammatory Cell purification
F4/80/ Mf cocultured with MEFs. We used PCR, and
limiting dilution PCR, to estimate the frequency of latently Both adherence and FACS sorting were used to purify
cells. For adherence, PECs were plated at 1 1 106 cells/infected Mf in vivo and the approximate copy number
of the MCMV genome in Mf from latently infected mice. ml in 175-cm2 flasks (Sarstedt) in R10. Following 30–33
hr incubation at 377 with 5% CO2 , flasks were gentlySince we found that resident and inflammatory Mf carry
MCMV genome with similar frequencies, and inflamma- washed and nonadherent cells collected. Adherent cells
were scraped in a minimal volume of phosphate-bufferedtory Mf are bone marrow-derived, we reasoned that the
Mf might obtain MCMV genome in the bone marrow saline (PBS). Adherent and nonadherent cells were pel-
leted, counted, and prepared for PCR analysis, cytospin,during latency. In support of this hypothesis we found
that bone marrow from latently infected mice contains and FACS analysis. For FACS sorting, PECs were stained
as previously described (Heise and Virgin, 1995) with theMCMV genome 3–9 months postinfection. These data
demonstrate that Mf are latently infected with MCMV, following exceptions. PECs were stained on ice with F4/
80, a Mf-specific monoclonal antibody (MAb) (Austynand are consistent with dissemination of latent Mf, de-
rived from the bone marrow, as a source of organ latency. and Gordon, 1981), and biotinylated anti-MHC class II
(Pharmingen, San Diego, CA), biotinylated anti-CD54
(ICAM-1; Pharmingen), or preconjugated anti-B220-phy-
MATERIALS AND METHODS
coerythrin (Pharmingen) in the presence of PBS with 2%
FCS. All MAbs were adjusted to 20 mg/ml for stainingCells and tissue culture media
except F4/80 hybridoma supernatant which was undi-
luted for staining. Secondary antibodies used were FITC-All media contained 100 U/ml penicillin and 100 mg/
ml streptomycin (Biofluids, Rockville, MD), 1% glutamine conjugated goat anti-rat IgG (Caltag, San Francisco, CA)
and phycoerythrin-conjugated streptavidin (Molecular(Biofluids), and 10 mM N-2-hydroxyethylpiperazine-N*-2-
ethanesulfonic acid (HEPES; Biofluids) and£0.025 ng/ml Probes, Eugene, OR). Cells were sorted on a FACS Van-
tage (Becton–Dickinson, San Jose, CA) or analyzed usingendotoxin. MEFs were generated by cultivation of minced
Balb/c mouse embryos (Days 14–16) in Dulbecco’s Mod- a Coulter Epics flow cytometer (Coulter, Miami, FL). Un-
sorted FACS-stained and F4/80-sorted cell populationsification of Eagle’s Medium (DMEM; Mediatech, Wash-
ington, DC), 10% fetal calf serum (FCS; HyClone, Logan, were counted in the presence of trypan blue by hemocy-
tometer prior to plating in reactivation studies. To charac-UT). MEFs were used during initial passaging or thawed
from frozen stocks. All MEFs were used before their 5th terize cells following adherence and FACS sorting, cytos-
pin differential counts were performed on Wright’spassage. PECs were harvested in HBSS 1% FCS
(HBSS/). Freshly isolated murine Mf were cultured in stained preparations as previously described (Heise and
Virgin, 1995).RPMI 10% FCS (R10).
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Reactivation in vitro following nested PCR is as sensitive as Southern blotting
(Pollock and Virgin, 1995).
Prior to assessing reactivation, tissues and cells were
analyzed for the presence of infectious MCMV by sonicat- Estimation of the frequency of cells carrying
ing to kill cells and culturing the resultant sonicate on MCMV genome
MEF monolayers for 14 days as previously described (Pol-
To determine the frequency of cells carrying MCMVlock and Virgin, 1995). To assess reactivation, 5 1 105 to
genome, we adapted published methods to detect1 1 106 PECs or purified Mf were cocultured with 0.5–
MCMV genome in serial dilutions of cells (Miyashita et1 1 105 MEFs. Cocultures were maintained in R10 with
al., 1995; Eron et al., 1992). Cells were diluted in watermedia changes every 3–4 days for at least 50 days. Reac-
so that each reaction tube received either 1 1 103, 3.3tivation was tested by transfer of cultured medium to fresh
1 103, or 1 1 104 cells, followed by addition of an equalMEF monolayers which were observed for cpe (Pollock
volume of lysis buffer (100 mM KCl, 20 mM Tris–HCl (pHand Virgin, 1995). Media from all wells without cpe after
 8.3), 5 mM MgCl2 , 1% Nonidet P-40, 1% Tween 20, and50 days were transferred to MEF monolayers to confirm
0.02% Proteinase K). An average of 25 PCR tubes perthe absence of infectious MCMV, and cells were collected
cell concentration were analyzed. Cells were lysed at 567for DNA isolation and nested PCR analysis.
for 12–48 hr in lysis buffer followed by a 15-min incuba-
tion at 957 to inactivate proteinase K. PCR cocktail was
Quantitation of MCMV DNA added directly to each lysate with adjustments in the
KCl, Tris–HCl, and MgCl2 , so that final PCR reactionCell and organ DNA from naive or latent animals was
conditions were as previously described (Pollock andprepared as described (Pollock and Virgin, 1995) with
Virgin, 1995). Nested PCR was performed on each sam-QIAamp Tissue kit (Qiagen, Chatsworth, CA) followed by
ple and reaction products were visualized by ethidiumtwo phenol-chloroform extractions and ethanol precipita-
bromide staining. Within every PCR reaction, negativetion. DNA samples were resuspended in 10 mM Tris with
controls included 3–10 reactions with lysis buffer or wa-1 mM EDTA (TE) and quantitated using DNA-specific
ter only. Positive controls in each PCR experiment in-Hoechst dye (Cytoprobe DNA Assay kit, Millipore, Bed-
cluded reactions with either 1, 10, and 104 –105 copiesford, MA). We previously showed that ie1 target plasmid
of pAMB25 added to lysis buffer alone or lysed cells.could be efficiently recovered when added to naive tissue
These positive controls demonstrated that the level ofsamples prior to DNA preparation (Pollock and Virgin,
sensitivity within every nested PCR reaction was the1995), demonstrating that MCMV sequences are effi-
same and that the presence of cells within the reactionsciently recovered and not selectively lost during prepara-
did not inhibit detection of MCMV genome.tion of DNA. DNA samples were adjusted to 0.1 mg/ml
with water, and serial dilutions were performed using
RESULTScarrier tRNA (Sigma, St. Louis, MO) at 0.1 mg/ml in water.
The amount of MCMV genome within a DNA sample Quantitation of MCMV genome during latency
was estimated by entering dilutions into a nested PCR
(Pollock and Virgin, 1995). The number of plasmid mole- Although MCMV DNA is found in many organs during
latency (Pollock and Virgin, 1995; Klotman et al., 1990;cules was calculated using the length of the plasmid in
base pairs (bp), the assumption of 660 g/mol/bp, and Balthesen et al., 1993; Pomeroy et al., 1991), we and
others have shown that the amount of MCMV genomeAvogadro’s number. Primers, buffers, and PCR conditions
were as previously described (Pollock and Virgin, 1995). within organs can vary (Pollock and Virgin, 1995; Yuhasz
et al., 1994; Balthesen et al., 1993). Elevated levels ofSensitivity was determined by adding known numbers of
copies of plasmid pAMB25, which contains the major MCMV genome in an organ may reflect an increase in
latently infected cells or an increase in the number ofimmediate early genes of MCMV (Koszinowski et al.,
1986), and performing nested PCR. Murine DNA samples MCMV genomes per latent cell. To identify latently in-
fected cells, we therefore developed both a quantitativewhich were negative for MCMV genome were tested with
primers for murine b-actin or murine cathepsin G gene nested PCR assay for MCMV genome content (this sec-
tion) and a limiting dilution PCR assay to determine theand contained amplifiable DNA sequences (data not
shown). We assumed 2.7 1 109 bp per haploid mouse frequency of cells carrying latent genome (below).
We previously showed that by using nested PCR undergenome or 1 mg of DNA per 172,000 diploid murine cells
(Lewin, 1990). The range of cellular DNA tested per reac- optimal conditions, the presence of an MCMV-specific
PCR product was all or none as detected by ethidiumtion was 1 ng to 1 mg DNA (c.a. 172 to 172,000 cell
equivalents of DNA) per reaction. Reaction products bromide or Southern blot (Pollock and Virgin, 1995). This
is presumed to be due to the extensive amplificationwere electrophoresed and stained with ethidium bromide
to detect ie1-specific product. Previous studies showed afforded by the second (nested) round of PCR. This assay
therefore has the advantage that it does not assumethat use of ethidium bromide to detect reaction products
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genome by PCR and reactivatable virus. To define the cell
type carrying latent MCMV in PECs, thioglycollate-elicited
PECs were harvested, counted, and divided for differential
counts, preparation of total DNA, and adherence assays.
Adherent and nonadherent cells were harvested and sam-
ples were taken for FACS analysis, differential counts, and
preparation of DNA. DNA from adherent PECs contained
significantly more MCMV genome than DNA from nonad-
herent cells, while adherent and total cells had similar
MCMV genome content (Fig. 2A).
Cellular components of total, adherent, and nonadher-
ent cells were quantitated by differential counts. Ninety-
six percent of adherent thioglycollate-elicited PECs pos-
sessed classic Mf morphology (Table 1), and no other
FIG. 1. Standard curve for quantitating MCMV genome in DNA from cell type was enriched in these cells. Selective enrich-
cell populations. Multiple nested PCR reactions were performed with
ment of Mf in adherent cells was confirmed using bothknown copy numbers of pAMB25 plasmid. The number of positive PCR
immunofluorescence and FACS staining for F4/80 (notreactions over the total number of PCR reactions performed at a given
input of target plasmid is provided for each point on the curve. shown). Nonadherent cells contained fewer Mf than ei-
ther total or adherent PECs, and were about fivefold en-
riched for lymphocytes. Since MCMV genome was en-
linear amplification of MCMV sequences for quantitation. riched in adherent compared to nonadherent PECs, the
In addition, we showed by mixing plasmid containing the data is most consistent with Mf carrying MCMV ge-
MCMV ie1 gene (pAMB25) with murine cells prior to nome. Adherence studies were repeated using resident
DNA isolation that target DNA is quantitatively recovered PECs. Adherent resident PECs were 93% F4/80/ by im-
during DNA isolation (Pollock and Virgin, 1995). Using munofluorescence, 92.7//0 0.5% F4/80/ by FACS analy-
nested PCR, we compared detection of MCMV se- sis, and 90.8% Mf by differential analysis (Table 1).
quences in samples containing dilutions of pAMB25 Again, adherent resident PECs, selectively enriched for
added to control DNA and dilutions of DNA from latently Mf, carried more MCMV genome than nonadherent cells
infected cells. We used the frequency of detection of (Fig. 2B).
MCMV sequences in these dilutions as a measure of
MCMV genome content.
FACS sorted F4/80/ Mf from latently infected miceWe quantitated the sensitivity of nested PCR for de-
carry MCMV genometecting MCMV sequences by adding known copy num-
bers of pAMB25 to nested PCR reactions (Fig. 1). Nested To test the hypothesis that Mf carry MCMV genome,
PCR detected 1 copy of pAMB25 in 80/168 (48%) of reac- FACS sorting was performed as an independent method
tions, and 10 copies in 211/220 (96%) reactions. Control (Fig. 3). Thioglycollate-elicited PECs were stained with
samples containing DNA from normal cells or water were F4/80 and either anti-MHC class II, anti-B220 (mouse
positive in 3/350 (1%) reactions over the course of CD45), or anti-ICAM1 (mouse CD54, Fig. 3A). Cells were
these experiments, demonstrating that the false-positive FACS sorted in five separate experiments as follows: (1)
rate of our assay is very low. To verify the reproducibility F4/80/ICAM1/ versus F4/800ICAM1/ populations (two
of the assay and the validity of the standard curve in Fig. experiments), (2) F4/800B220/ versus F4/80/B2200 pop-
1, we tested multiple plasmid stocks, tested both linear ulations (one experiment), or (3) F4/800MHC Class II/
and circular supercoiled plasmid (Pollock and Virgin, versus F4/80/MHC Class II/ populations (two experi-
1995), quantitated plasmid DNA in multiple dilutions, and ments). These conditions were selected so that MCMV
performed multiple dilutions with defined numbers of DNA content could be compared between Mf and other
copies of target plasmid per reaction. With this assay in major cell types in PECs [B cells, NK cells, granulocytes,
hand we proceeded to purify cell populations from la- and other lymphocytes, (Coffman, 1982; Ballas and Ras-
tently infected mice and determined MCMV genome con- mussen, 1993; Heise and Virgin, 1995)].
tent. Twenty-six postsort analyses across the five experi-
ments showed that F4/80/ populations (e.g., Fig. 3A, right
Adherent peritoneal cells (enriched for Mf) are
panel) were 95.8 //0 0.4% pure with 0.6 //0 0.1% con-
carriers of MCMV DNA
tamination from the F4/800 populations (Table 2). Differ-
ential counts showed that 89% of F4/80/ cells were MfTo assure that we analyzed latent cells, we waited 3 to
9 months post MCMV infection (Pollock and Virgin, 1995). (Table 1), while an additional 6% were either monocytes
or lymphoblasts by morphology. We could not alwaysInitial experiments showed that both resident and elicited
PECs from latently infected Balb/c mice contained MCMV distinguish monocytes and lymphoblasts on morphologic
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FIG. 2. Adherent PECs contain more MCMV genome than nonadherent cells. MCMV genome was quantitated in DNA from total PECs, adherent
PECs, or nonadherent PECs from latently infected mice. Cells were allowed to adhere for 30–33 hr prior to collection of adherent and nonadherent
populations and preparation of total DNA. DNA samples were serially diluted in tRNA and subjected to nested PCR for MCMV ie1 gene sequences.
Data is reported as the percentage of PCR reactions positive at each dilution of total DNA. Samples negative for MCMV genome were positive for
PCR amplification of either murine b-actin or murine cathepsin G gene. (A) Thioglycollate-elicited PECs. The data represents percentages derived
from a total of at least 5 reactions per DNA dilution across 5–8 experiments. (B) Resident PECs. Data represents 4–17 PCR reactions/dilution
across 2–3 experiments.
criteria. F4/80/ cells contained MCMV DNA at levels F4/80/ Mf are the major cell type in thioglycollate-elic-
ited PECs which carry MCMV genome.comparable to total PECs (Fig. 3B), demonstrating that
positively selected F4/80/ Mf carry MCMV genome.
Over the five experiments, F4/800 cells (e.g., Fig. 3A, left Reactivation of MCMV from PECs and sorted
panel) never contained detectable MCMV genome. All F4/80/ Mf
samples from F4/800 cells tested positive for PCR ampli-
fication of actin sequences (Pollock and Virgin, 1995; not Studies in both adherent and FACS-sorted cells showed
that Mf carry MCMV genome during latency. We thereforeshown). F4/800 cells were enriched for lymphocytes and
neutrophils and contained less than 1% Mf (Table 1). evaluated reactivation of MCMV from PECs and sorted F4/
80/ Mf in long term cocultures with MEFs as previouslySince F4/800 cells did not contain detectable MCMV ge-
nome and were enriched for cell types other than Mf, described (Pollock and Virgin, 1995) (Table 3). To assure
TABLE 1
Differential Counts of Starting and Purified Cell Populations
Percentage of cell type in populationa
Lymphoblast or
Macrophages Lymphocytes monocyteb Neutrophils Basophils Eosinophils
Resident PECs 33.7 { 4.6 20 { 5.6 42.6 { 6.5 0.5 { 0.2 2.8 { 0.8 0.2 { 0.1
Adherent 90.8 { 2.9 0.2 { 0.2 4.9 { 4.1 0 3.9 { 1.3 0
Nonadherent 28.9 { 11.3 20 { 5.8 49.7 { 5.8 0.1 { 0.1 0.8 { 0.4 0.3 { 0.2
Thioglycollate elicited PECsc 76 { 2 7.2 { 2.8 7.4 { 3.2 3.3 { 1 0.9 { 0.8 5.3 { 1.6
Adherent 96.4 { 0.6 0.2 { 0.2 3.3 { 0.6 0 0.2 { 0.2 0
Nonadherent 22.5 { 8 36.6 { 8 27 { 5.7 1 { 0.3 1.8 { 0.4 10.6 { 3
Sortedd F4/80/ 89 { 5.4 1.8 { 0.8 5.7 { 1.9 0.1 { 0.1 0.1 { 0.1 3 { 1.3
Sortedd F4/800 0.9 { 0.4 54.5 { 5.3 30.7 { 5 9.7 { 5 0.7 { 0.4 0.2 { 0.1
a These numbers were derived from the following number of experiments: total resident, n  5; adherent resident, n  3; nonadherent resident,
n  3; total thioglycollate, n  7; adherent thioglycollate, n  3; nonadherent thioglycollate, n  3; sorted F4/80/, n  4; sorted F4/800, n  6. In
all cases smears were read in a blinded fashion by J.P.
b Monocytes could not always be dependably distinguished from lymphoblasts on morphologic grounds.
c PECs harvested 2–3 days after intraperitoneal administration of thioglycollate.
d Date is pooled from all five sorting experiments.
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FIG. 3. Purification of Mf by FACS sorting. (A) PECs were stained with ICAM and F4/80 (center) and gated to select ICAM/, F4/800 cells and
ICAM/, F4/80/ cells. Samples from each selected population were analyzed at multiple times during the sorting procedure to determine purity. A
typical example is shown of F4/80/ sorted cells (right) and F4/800 cells (left). (B) Nested PCR of sort purified populations was performed. DNA from
each sample was diluted in tRNA and tested for presence or MCMV ie1 DNA. DNA samples were tested an average of 7 times per dilution from 5
separate experiments. All samples which were negative for MCMV DNA were positive for amplification when tested in a PCR for mouse actin.
that cell populations did not contain detectable preformed creased. As a control for possible alteration of reactivation
frequency by FACS staining, we stained cells but did notinfectious virus on the day of harvest, we sonicated PECs
and cultured samples with MEFs as described (Pollock sort them. FACS staining did not appreciably alter reactiva-
tion frequency. FACS sorted F4/80/ peritoneal Mf reacti-and Virgin, 1995). An average of 6 1 106 PECs were ana-
lyzed per culture in a total of 19 cultures and none con- vated in 6/19 cultures. Thus, F4/80/ peritoneal Mf carry
both MCMV genome and reactivatable virus, but not de-tained infectious MCMV. These experiments showed that
PECs did not carry detectable infectious MCMV during tectable preformed infectious virus, and are therefore la-
tently infected with MCMV.latency. To assess reactivation, cell populations were cul-
tured with MEFs for 50 days or until reactivation led to
complete cpe. Culture media were tested by transfer to Resident and thioglycollate-elicited PECs carry MCMV
MEF monolayers (Pollock and Virgin, 1995) twice weekly genome at similar frequencies
to detect infectious virus. All cell populations containing
Mf reactivated MCMV (Table 3). The frequency of reactiva- We next addressed the possibility that Mf entering
the peritoneum in response to thioglycollate-induced in-tion was increased when the PECs per culture were in-
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TABLE 2
Purity of F4/80 Sorts Using Postsort Analysis
Percentage of Percentage of purity Percentage of
Populations sorted purity for F4/80 for other cell type contamination
1 and 2 F4/80/ 96.8% { 0.18 0.2% { 0.3
F4/800, Class IIhi 80% { 2.8 3.6 { 1.3
3 F4/80/ 96.7% { 0.33 0.05% { 0.02
F4/800, B220/ 87.7% { 2.3 0.77 { 0.2
4 F4/80/ 95 { 1.4 0.9 { 0.3
F4/800, ICAM-1 91.4% { 1.3 1.7% { 1.2
5 F4/80/ 93.6% { 0.7 1.3% { 0.3
F4/800, ICAM-1 88.1% { 4.3 2.1% { 0.87
flammation carry MCMV genome. By comparing the fre- mice per group (a total of five mice evaluated) and tested
14 to 36 reactions per dilution of cells. Reactions withquencies with which Mf carry MCMV genome in resi-
dent and elicited PECs, we could determine whether Mf fewer than 1 1 104 cells were also performed to demon-
strate that the frequency of positive reactions diluted outin elicited PECs carry MCMV genome. The frequency
with which Mf carry MCMV genome was determined with the number of cells per reaction (not shown). From
the initial three experiments, we found that samples con-by adding serial dilutions of resident and thioglycollate-
elicited PECs to multiple PCR tubes, lysing the cells, taining 104 resident PECs contained detectable MCMV
genome in 37/101 (37.6%) reactions (Table 5, experi-and assaying for MCMV genome by nested PCR for ie1
sequences. To quantitate PCR sensitivity in the presence ments 1–3). Since we efficiently detect a single copy of
the MCMV genome, we estimate that a cell containingof cell lysates, 1 or 10 copies of plasmid carrying ie1
sequences were added to lysis buffer, or 103 –104 MCMV MCMV genome is present in about 1 cell/27,000 PECs
(104/.376). We then determined the frequency of cellsgenome-negative cells, and assayed by nested PCR (Ta-
ble 4). One copy of plasmid was detected 67% of the carrying MCMV genome in thioglycollate-elicited PECs.
Testing 104 elicited cells per reaction, 32/85 reactionstime in lysis buffer alone and 59% of the time in tubes
containing 104 PECs or bone marrow cells. Ten copies (37.6%) were positive for the presence of the MCMV ge-
nome. Thus, in the initial three experiments, the fre-of plasmid were detected 100% of the time in lysis buffer
alone and 97% of the time in samples containing 104 quency of MCMV genome positive cells in resident and
thioglycollate-elicited PECs was comparable. However,cells. We therefore efficiently detect one copy of MCMV
sequence in samples containing lysates from up to 104 between different experiments variation in frequency was
seen. This variation was not explained by differences incells.
To estimate the frequency of MCMV genome-positive latent mice (dose, time after infection).
To avoid mouse to mouse variation, and recover elic-cells in resident PECs from latently infected mice, 104
resident PECs were assayed per reaction a total of 101 ited PECs with less contamination by resident PECs, we
harvested resident PECs and thioglycollate-elicited PECstimes (Table 5). We used one to three latently infected
from the same animal (Table 5, experiments 4–8). Resi-
TABLE 3
TABLE 4Reactivation of MCMV from Mf Populations
Sensitivity of Nested PCR for MCMV Genome in Dilutions of Cells
Number
Cells/ reactivating Positive PCR reactions/Total PCR reactions
culture MCMV/total
Cell population (No. of experiments) (1105) cultures No added Add 1 copy Add 10 copies
target plasmid target plasmid target plasmid
PECs/Adherent PECsa (n  3) 5–10 5/51 (10%)
Lysis buffer 1/87 (1.1%) 32/48 (67%) 34/34 (100%)Adherent PECs (n  4) 50–100 9/19 (47%)
10,000 cellsa 0/176 (0%) 26/44 (59%) 31/32 (97%)
3,300 cells 0/78 (0%) 16/30 (53%) 20/20 (100%)F4/80 stained, unsorted PECs (n  4) 9–10 4/17 (24%)
1,000 cells ND 15/21 (71%) 7/7 (100%)
F4/80/ sorted PECs (n  4) 9–10 6/19 (32%)
Total 1/341 (0.3%) 89/143 (62%) 92/93 (99%)
a Total PECs were plated and in some cases the nonadherent cells
were removed by washing after 30–33 hr. a MCMV genome-negative PECs and bone marrow cells.
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TABLE 5
Frequency of Cells Carrying MCMV Genome in PECs from Latently Infected Mice
Frequency of MCMV
PECs/mouse (1 106) Limiting dilution PCRa positive cellsb
Experiment Resident Elicitedc Resident Elicited Resident Elicited
1 (4)d 5.8 26 (4.5)e 3/32 2/36 1/107,000 1/180,000
2 (2) 3.1 22 (7) 33/35 25/35 1/11,000 1/14,000
3 (2) 2.7 25 (9) 1/34 5/14 1/340,000 1/28,000
4 (1) 2.0 31 (15.5) 2/21 8/32 1/105,000 1/40,000
5 (1) 2.5 30 (12) 5/26 3/32 1/52,000 1/107,000
6 (1) 2.8 19 (6.8) 6/32 3/32 1/53,000 1/107,000
7 (1) 3.5 14 (4) 5/32 2/32 1/64,000 1/160,000
8 (1) 2.6 26 (10) 5/32 3/32 1/64,000 1/107,000
Total 3.1 24 (8.6) 60/244 49/245 1/40,000 1/50,000
a Data are presented as the number of positive MCMV, ie1 DNA PCRs over the number of total limiting dilution PCRs performed with 104 cells.
b The frequency of cells carrying the MCMV genome was determined by dividing the number of positive reactions by the total number of cells
tested (reactions 1 cells/reaction).
c Thioglycollate-elicited PECs.
d Number in parentheses indicates the number of mice in that experiment.
e Number in parentheses indicates the fold increase in PECs from resident PECs. In dual harvest experiments, fold increase was determined
based on the number of resident PECs even though resident PECs had been depleted in those studies.
dent cells were harvested from anesthetized mice by removed the majority of resident PECs from these mice.
Twenty-four hours after initial lavage, mice were injectedgentle passage of HBSS through the peritoneum. We
recovered approximately as many resident PECs using i.p. with thioglycollate. Three days later, mice were sacri-
ficed and elicited PECs were harvested. Resident andthis method as we recovered after sacrifice and perito-
neal lavage (Table 5, compare PECs/mouse in experi- elicited PECs were counted and analyzed by limiting dilu-
tion PCR. A total of five mice were tested in this fashion.ments 1–3 versus 4–8). This indicates that we effectively
TABLE 6
Estimated MCMV Genome Copies per Cell in PECs and Bone Marrow
Frequency of MCMV MCMV genomes/
Cells positive cellsa MCMV genome frequencyb genome-positive cell
PECsc 1/40,000 1/11,500 3.5
1/107,000 1/137,600 0.8
1/9,900 1/24,100 0.4
1/106,700 1/51,600 2.1
1/106,700 1/158,200 0.7
Bone marrow cells 1/26,750 1/20,600 1.2
1/37,500 1/9,000 4.2
1/80,000 1/20,600 3.9
1/31,250 1/37,800 0.8
1/35,700 1/43,000 0.8
1/35,700 1/48,200 0.7
1/21,100 1/12,000 1.8
1/39,600 1/12,000 3.3
1/39,600 1/8,600 4.6
1/24,800 1/20,600 1.2
1/16,500 1/20,600 0.8
a The frequency of cells carrying MCMV genome was determined by limiting dilution PCR. Fifteen to 32 reactions were performed per sample in
the limiting dilution PCR.
b To determine MCMV genome content, we performed at least 3 separate serial dilutions and performed a total of 3–18 PCRs per dilution of
DNA. The frequency of detection of MCMV genome in these dilutions was compared to the standard curve for detection of pAMB25 (see Fig. 1),
and the MCMV genome content per cell equivalent of DNA determined using the amount of DNA that was positive in 50% of PCRs.
c Thioglycollate-elicited PECs.
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In these five mice 23/143 (16.1%) reactions containing infected cell in PECs, Mf which carry MCMV during
latency contain about 1–10 copies of MCMV genome.104 cells were positive for resident PECs, while 19/160
(11.9%) reactions remained positive following depletion
of resident PECs and elicitation of a Mf infiltrate. The DISCUSSION
fact that resident and elicited PECs carry genome at
We demonstrate that murine Mf are latently infectedcomparable frequencies in these studies shows that infil-
with MCMV 3 to 9 months postinfection. Evaluation oftrating Mf carry MCMV genome. Across all eight experi-
latency 3–9 months after infection decreased the chancements 1/40,000 resident PECs carried genome, while 1/
that persistent MCMV infection, which may last up to 1–50,000 elicited PECs carried genome (Table 5).
2 months, would confound our analysis. Mf enriched by
either adherence or FACS sorting contained MCMV DNABone marrow cells from latently infected mice contain
by nested PCR and reactivated MCMV. This confirmsMCMV genome
and extends results first obtained by Brautigam et al.,
Since resident and thioglycollate-elicited Mf carry demonstrating MCMV in adherent peritoneal cells from
MCMV genome with similar frequencies, and inflamma- chronically infected mice (Brautigam et al., 1979). Since
tory Mf are bone marrow derived (see Discussion), we resident and inflammatory Mf carry MCMV genome in
hypothesized that the bone marrow was one likely source similar amounts, and with similar frequencies, we hy-
for Mf carrying MCMV genome. Bone marrow cells were pothesized that Mf carrying MCMV genome originate in
harvested and tested for persistent virus as previously the bone marrow. Consistent with this hypothesis, we
described (Pollock and Virgin, 1995). Four to six months found MCMV genome, in the absence of detectable in-
after infection, 20 samples (from 40 mice) containing an fectious MCMV, in bone marrow cells from latent mice.
average of 1.4 1 107 cells were sonicated, cultured with These data do not address the possibility that MCMV
MEFs, and found not to contain any detectable preformed may be latent in cell types in addition to Mf (Olding et
infections virus. Twenty of twenty samples from the same al., 1975; Jordan and Mar, 1982; Mercer et al., 1988;
mice contained MCMV DNA when bone marrow cell DNA Pomeroy et al., 1991), but do provide proof that Mf are
was evaluated by nested PCR. We evaluated the fre- latently infected with MCMV. Latent cells carried about
quency of cells carrying MCMV genome in bone marrow 1–10 copies of MCMV genome.
and found it to be similar to the frequency of genome
bearing cells in inflammatory Mf. While we have not Mf are latently infected with MCMV
identified Mf progenitors as cells with MCMV DNA in
Previous work suggested Mf, B cells, and stromalthe bone marrow, presence of viral genome in the bone
cells (Brautigam et al., 1979; Mercer et al., 1988; Pomeroymarrow is consistent with the bone marrow as a site of
et al., 1991; Jordan and Mar, 1982; Olding et al., 1975)latency.
as candidates for latent MCMV infection. Since PECs
contain both B cells and Mf, we evaluated PECs forCells carrying MCMV DNA during latency contain
latent MCMV. In experiments using both adherence and1–10 copies of the MCMV genome
sorting, Mf enriched populations and total peritoneal
By determining both the total MCMV genome in DNA cell populations contained comparable amounts of
isolated from a cell population, and the frequency of cells MCMV genome (Figs. 2 and 3B). This is consistent with
carrying MCMV genome, we estimated the number of Mf carrying MCMV genome since Mf make up 76% of
MCMV genomes per cell during latency. Bone marrow thioglycollate-elicited PECs and thus are enriched only
cells and thioglycollate-elicited PECs were analyzed for 1.2- to 1.3-fold in either adherent cells or F4/80/ cells.
the frequency of cells carrying viral genome by limiting
dilution PCR. We estimated the frequency of genome The frequency of Mf containing viral genome during
carrying cells in dilutions which yielded less than 60% latency and the number of MCMV genomes per cell
positive reactions in order to calculate frequencies from from latently infected mice
primarily single events. The total amount of MCMV ge-
nome was determined by serially diluting cellular DNA, We used a limiting dilution PCR assay to quantitate
the frequency of Mf carrying MCMV genome during la-performing nested PCR for MCMV ie1, and comparing
the results to a standard curve (Fig. 1). Sixteen experi- tency. The frequency of detection of one copy of pAMB25
in lysate from cells is not significantly different from thatments were performed on either thioglycollate-elicited
PECs or total bone marrow cells. The range of MCMV predicted by the Poisson distribution (59 versus 63% pre-
dicted). Since a latently infected cell must carry at leastgenome copies per cell was from 0.4 to 4.6 (Table 6).
Bone marrow cells were analyzed in 11 experiments, and one copy of the genome, the assay can therefore detect
latently infected cells. We estimated that 1/40,000 to 1/we estimate 2.1 //0 1.4 copies per cell. For PECs, five
experiments were performed and we estimate 1.5 //0 50,000 PECs contains MCMV genome during latency (Ta-
ble 5). This estimated frequency is similar to estimates1.1 copies per cell. Since the Mf is the major latently
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of the number of B cells carrying EBV genome in circula- cytes contain HCMV DNA in seropositive individuals
(Taylor-Wiedeman et al., 1991). Monocyte/Mf carriagetion in seropositive people, which ranges from 1/16,000
to 1/434,000 with an average frequency 1/80,000 (Miyas- of CMV genome is not likely to be due to productive
infection (this report and Pollock and Virgin, 1995; Taylor-hita et al., 1995). To estimate the number of copies of
MCMV genome per latently infected cell, the frequency Wiedeman et al., 1994). DNA for both viruses can be
found in bone marrow (this report and Maciejewski etof cells carrying genome was compared to the total
amount of genome present (Table 6). The resulting esti- al., 1992; Minton et al., 1994; Kondo et al., 1994; Yuhasz
et al., 1994). As predicted for a cellular site of long termmate of 1–10 copies of genome per latent cell supports
our earlier conclusion that MCMV is predominantly latent latency, granulocyte/Mf progenitors are relatively resis-
tant to lytic infection with both MCMV (Busch et al., 1991;rather than persistent in Balb/c mice (Pollock and Virgin,
1995). We expect that cells actively replicating MCMV Gibbons et al., 1995; Petursson et al., 1984) and HCMV
(Sing and Ruscetti, 1990; Minton et al., 1994; Maciejewskiwould contain significantly more than 1–10 copies of
genome per cell. et al., 1992; Kondo et al., 1994; Simmons et al., 1990).
HCMV genome can replicate in granulocyte/Mf progeni-
Origin of Mf carrying MCMV genome during latency tors in the presence of ganciclovir, demonstrating that
this lineage can harbor CMV genome without ongoing
The finding of latent MCMV in tissue Mf does not
persistent infection (Kondo et al., 1994). This is consistent
alone explain life-long latency. Mf in the mouse are
with a model in which Mf obtain MCMV genome in the
predicted to turn over completely in the peritoneum or
bone marrow, perhaps from progenitor cells, and then
other organs about every 40–80 days (van Furth, 1970;
disseminate to tissues establishing systemic latency.
van Furth and Cohn, 1968). Unless latently infected Mf
have a survival advantage in tissue over normal Mf [e.g.,
Multiple roles of Mf during MCMV infectionvia MCMV blockade of apoptosis (Zhu et al., 1995)], pro-
longed tissue latency could only be explained by addi- Mf play a variety of roles during CMV infection. They
tional longer lived latent cell types or replenishment of are a primary cell type in inflammatory exudates elicited
latent tissue Mf. One potential source of latent cells to by MCMV infection (Heise and Virgin, 1995), their activa-
replenish latent tissue Mf would be circulating mono- tion/differentiation is altered during acute CMV infection
cytes. A role for Mf in dissemination of MCMV during (Heise and Virgin, 1995; Price et al., 1987), and they are
acute infection has been suggested (Stoddart et al., 1994; important for disseminating CMV infection (Bale and
Bale and O’Neil, 1989; Collins et al., 1994). These Mf O’Neil, 1989; Stoddart et al., 1994; Saltzman et al., 1988;
might obtain viral genome in the bone marrow since Collins et al., 1994). Last, both HCMV and MCMV utilize
MCMV and MCMV genome-positive cells are present in the monocyte/Mf lineage to harbor viral genome during
bone marrow during acute infection (Bale et al., 1987; latency. Elucidating the mechanisms responsible for
Yuhasz et al., 1994). A similar process might disseminate acute and chronic interactions between CMV and the
latently infected Mf for a prolonged period after infec- Mf lineage is an important goal, since it may present
tious virus is cleared. opportunities for prevention or treatment of CMV disease
We therefore considered the hypothesis that perito- in immunocompromised hosts.
neal Mf carrying MCMV genome during latency were
bone marrow-derived. We found that the MCMV genome
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